PROTHENA CORPORATION PUBLIC LIMITED COMPANY Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals
PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) had Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals of $14.60 million as of 2018-12-31, per its 10-K filed 2020-03-03.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals · last filed 2020-03-03
- 2018-12-31: Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals $14.60M.
- 2018-09-30: Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals $15.24M.
| Period end | Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals |
|---|---|
| 2018-12-31 | $14.60M 10-K · filed 2020-03-03 |
| 2018-09-30 | $15.24M 10-Q · filed 2018-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |